You have free access to this content

Epilepsia

Cover image for Vol. 54 Issue s2

Special Issue: Pharmacoresistance in Epilepsy: 2nd Halifax International Epilepsy Conference & Retreat, September 21–22, 2012—Halifax, Nova Scotia, Canada

May 2013

Volume 54, Issue Supplement s2

Pages 1–85

  1. INTRODUCTION

    1. Top of page
    2. INTRODUCTION
    3. EPIDEMIOLOGY AND CLINICAL ASPECTS OF PHARMACORESISTANCE
    4. NEUROBIOLOGY MODELS OF PHARMACORESISTANCE IN EPILEPSY
    5. NEURODIAGNOSTICS OF PHARMACORESISTANCE
    6. SYNOPSIS
    1. You have free access to this content
      The puzzle(s) of pharmacoresistant epilepsy (pages 1–4)

      Bernd Pohlmann-Eden and Donald F. Weaver

      Version of Record online: 3 MAY 2013 | DOI: 10.1111/epi.12174

  2. EPIDEMIOLOGY AND CLINICAL ASPECTS OF PHARMACORESISTANCE

    1. Top of page
    2. INTRODUCTION
    3. EPIDEMIOLOGY AND CLINICAL ASPECTS OF PHARMACORESISTANCE
    4. NEUROBIOLOGY MODELS OF PHARMACORESISTANCE IN EPILEPSY
    5. NEURODIAGNOSTICS OF PHARMACORESISTANCE
    6. SYNOPSIS
    1. The International League Against Epilepsy and Wiley have published this supplement without financial support.

      You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
    4. You have free access to this content
    5. You have free access to this content
    6. You have free access to this content
      Prevention of sudden unexpected death in epilepsy: A realistic goal? (pages 23–28)

      Philippe Ryvlin, Lina Nashef and Torbjörn Tomson

      Version of Record online: 3 MAY 2013 | DOI: 10.1111/epi.12180

  3. NEUROBIOLOGY MODELS OF PHARMACORESISTANCE IN EPILEPSY

    1. Top of page
    2. INTRODUCTION
    3. EPIDEMIOLOGY AND CLINICAL ASPECTS OF PHARMACORESISTANCE
    4. NEUROBIOLOGY MODELS OF PHARMACORESISTANCE IN EPILEPSY
    5. NEURODIAGNOSTICS OF PHARMACORESISTANCE
    6. SYNOPSIS
    1. The International League Against Epilepsy and Wiley have published this supplement without financial support.

      You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
      The methylation hypothesis of pharmacoresistance in epilepsy (pages 41–47)

      Katja Kobow, Assam El-Osta and Ingmar Blümcke

      Version of Record online: 3 MAY 2013 | DOI: 10.1111/epi.12183

    4. You have free access to this content
    5. You have free access to this content
  4. NEURODIAGNOSTICS OF PHARMACORESISTANCE

    1. Top of page
    2. INTRODUCTION
    3. EPIDEMIOLOGY AND CLINICAL ASPECTS OF PHARMACORESISTANCE
    4. NEUROBIOLOGY MODELS OF PHARMACORESISTANCE IN EPILEPSY
    5. NEURODIAGNOSTICS OF PHARMACORESISTANCE
    6. SYNOPSIS
    1. The International League Against Epilepsy and Wiley have published this supplement without financial support.

      You have free access to this content
    2. You have free access to this content
      Is routine electroencephalography (EEG) a useful biomarker for pharmacoresistant epilepsy? (pages 63–66)

      Bernhard J. Steinhoff, Julia Scholly, Christel Dentel and Anke Maren Staack

      Version of Record online: 3 MAY 2013 | DOI: 10.1111/epi.12187

    3. You have free access to this content
    4. You have free access to this content
    5. You have free access to this content
      A conceptual framework for the use of neuroimaging to study and predict pharmacoresistance in epilepsy (pages 75–79)

      Bernd Pohlmann-Eden, Candice E. Crocker and Matthias H. Schmidt

      Version of Record online: 3 MAY 2013 | DOI: 10.1111/epi.12190

  5. SYNOPSIS

    1. Top of page
    2. INTRODUCTION
    3. EPIDEMIOLOGY AND CLINICAL ASPECTS OF PHARMACORESISTANCE
    4. NEUROBIOLOGY MODELS OF PHARMACORESISTANCE IN EPILEPSY
    5. NEURODIAGNOSTICS OF PHARMACORESISTANCE
    6. SYNOPSIS
    1. The International League Against Epilepsy and Wiley have published this supplement without financial support.

      You have free access to this content
      Pharmacoresistant epilepsy: Unmet needs in solving the puzzle(s) (pages 80–85)

      Donald F. Weaver and Bernd Pohlmann-Eden

      Version of Record online: 3 MAY 2013 | DOI: 10.1111/epi.12191

SEARCH

SEARCH BY CITATION